SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-105284
Filing Date
2020-04-13
Accepted
2020-04-13 16:36:39
Documents
12
Period of Report
2020-04-13
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K d868038d8k.htm   iXBRL 8-K 30124
  Complete submission text file 0001193125-20-105284.txt   158181

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA amrn-20200413.xsd EX-101.SCH 3076
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE amrn-20200413_lab.xml EX-101.LAB 18840
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amrn-20200413_pre.xml EX-101.PRE 11843
13 EXTRACTED XBRL INSTANCE DOCUMENT d868038d8k_htm.xml XML 3927
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21392 | Film No.: 20789090
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences